Sara Jeevanjee, MD

Title(s)Assistant Clinical Professor, Medicine
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    I completed residency in the Primary Care Internal Medicine (UCPC) program at UCSF in 2012, after which I joined the faculty in the Division of Hospital Medicine at San Francisco General Hospital as a hospitalist on the Faculty Inpatient Service (FIS).

    • M.D: Temple University
    • B.S.: Haverford College

    • UC Primary Care Internal Medicine, UCSF (internship and residency)

    • License, Medical Board of California
    • DEA
    • Board Certified in Internal Medicine

    Memberships & Affiliations:
    • Society for General Internal Medicine

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Jeevanjee S, Penko J, Guzman D, Miaskowski C, Bangsberg DR, Kushel MB. Opioid analgesic misuse is associated with incomplete antiretroviral adherence in a cohort of HIV-infected indigent adults in San Francisco. AIDS Behav. 2014 Jul; 18(7):1352-8. PMID: 24077929; PMCID: PMC3969410.
    2. Jeevanjee S, Penko J, Guzman D, Miaskowski C, Bangsberg D, Kushel M.AIDS an Behavior. Opioid Analgesic Misuse is Associated with Incomplete Antiretroviral Adherence in a Cohort of HIV-Infected Indigent Adults in San Francisco. 2013.
    3. Jeevanjee S.Section author for infectious disease chapter: Prophylaxis for opportunistic infections and vaccine recommendations in HIV infected patients, Pulmonary infections in HIV infected patients, Immune reconstitution inflammatory syndrome, Evaluation of fever in injection drug users. In Schwartz B, Gandhi M, editors. UCSF Hospitalist Handbook. San Francisco: UCSF. 2012.
    4. Stromnes IM, Blattman JN, Tan X, Jeevanjee S, Gu H, Greenberg PD. Abrogating Cbl-b in effector CD8(+) T cells improves the efficacy of adoptive therapy of leukemia in mice. J Clin Invest. 2010 Oct; 120(10):3722-34. PMID: 20890046; PMCID: PMC2947221.